Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer (Frontiers in Oncology, (2022), 12, (931445), 10.3389/fonc.2022.931445)

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

In the published article, there was an error in the Funding statement. The Grant number for the Natural Science Foundation of Hebei Province was displayed as “H20202063”. The correct Funding statement appears below. The correct Funding statement is “This work was supported by grants from the Natural Science Foundation of Hebei Province (Grant number: H2020206385).” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Cite

CITATION STYLE

APA

Zuo, W. W., Zhao, C. F., Li, Y., Sun, H. Y., Ma, G. M., Liu, Y. P., & Kang, S. (2023). Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer (Frontiers in Oncology, (2022), 12, (931445), 10.3389/fonc.2022.931445). Frontiers in Oncology. Frontiers Media SA. https://doi.org/10.3389/fonc.2023.1218746

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free